Patent Foramen Ovale (PFO) Closure Devices Market Size, Share, Outlook, and Opportunity Analysis, 2022-2028
Patent Foramen Ovale (PFO) Closure Devices Market
PFO is a medical disorder in
which a tissue flap in the wall between the left and right atrium remains
permanently open, enabling a tiny flow of blood to move from the right to the
left side of the heart.
Over the projected period, the
high incidence rate of ischemic stroke is expected to drive the growth of the
global patent foramen ovale (PFO) closure devices market. Stroke is one of the
leading causes of death worldwide. According to the American Stroke
Association, around 795,000 persons in the United States suffer from stroke
each year, with ischemic strokes accounting for approximately 87% of all
strokes. Furthermore, rising alcohol intake, increased smoking, and sedentary
lifestyle are all likely to raise the risk of stroke.
Furthermore, the global
prevalence of congenital heart disease is predicted to drive the growth of the global
patent foramen ovale (PFO) closure devices market. According to the
American Heart Association, over 40,000 babies in the United States are born
with a congenital heart problem, and over 2-3 million Americans suffer from
congenital heart disorders.
Product recall and/or
discontinuation are projected to stifle growth in the global patent foramen
ovale (PFO) closure devices market. For example, after being sued for patent
infringement, W. L. Gore & Associates, Inc stopped its product GORE HELEX
Septal Occluder in 2013. Furthermore, St. Jude Medical issued a Class I recall
for its Amplatzer TorqVue FX Delivery System, which is utilised in
transcatheter repair of atrial septal defects (ASDs).
Comments
Post a Comment